Global Familial Amyloid Polyneuropathy Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

October 2018 | 116 pages | ID: G977ABD46A0GEN
GlobalInfoResearch

Abstracts

Familial amyloid polyneuropathy (FAP) or transthyretin (TTR) amyloid neuropathy are a rare group of autosomal dominant diseases caused by the deposition of protein and/or amyloid fibrils around the peripheral nerves and in various tissues, including the heart muscle.

SCOPE OF THE REPORT:

Globally, development of new drugs for treatment of familial amyloid polyneuropathy, and rise in the prevalence of familial amyloid polyneuropathy are the prime growth drivers of familial amyloid polyneuropathy market.
The global Familial Amyloid Polyneuropathy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Familial Amyloid Polyneuropathy.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Familial Amyloid Polyneuropathy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Familial Amyloid Polyneuropathy market by product type and applications/end industries.
Market Segment by Companies, this report covers

• Pfizer
• GSK
• Ionis
• Alnylam
• Corino Therapeutics
• Proclara Bioscience
• Arcturus Therapeutics

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• FAP-I
• FAP-II
• FAP-III
• FAP-IV

Market Segment by Applications, can be divided into

• Hospitals and Clinics
• Others

Contents

1 FAMILIAL AMYLOID POLYNEUROPATHY MARKET OVERVIEW

1.1 Product Overview and Scope of Familial Amyloid Polyneuropathy
1.2 Classification of Familial Amyloid Polyneuropathy by Types
  1.2.1 Global Familial Amyloid Polyneuropathy Revenue Comparison by Types (2017-2023)
  1.2.2 Global Familial Amyloid Polyneuropathy Revenue Market Share by Types in 2017
  1.2.3 FAP-I
  1.2.4 FAP-II
  1.2.5 FAP-III
  1.2.6 FAP-IV
1.3 Global Familial Amyloid Polyneuropathy Market by Application
  1.3.1 Global Familial Amyloid Polyneuropathy Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Hospitals and Clinics
  1.3.3 Others
1.4 Global Familial Amyloid Polyneuropathy Market by Regions
  1.4.1 Global Familial Amyloid Polyneuropathy Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Familial Amyloid Polyneuropathy Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Familial Amyloid Polyneuropathy Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Familial Amyloid Polyneuropathy Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Familial Amyloid Polyneuropathy Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Familial Amyloid Polyneuropathy Status and Prospect (2013-2023)
1.5 Global Market Size of Familial Amyloid Polyneuropathy (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Pfizer
  2.1.1 Business Overview
  2.1.2 Familial Amyloid Polyneuropathy Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Pfizer Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.2 GSK
  2.2.1 Business Overview
  2.2.2 Familial Amyloid Polyneuropathy Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 GSK Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.3 Ionis
  2.3.1 Business Overview
  2.3.2 Familial Amyloid Polyneuropathy Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Ionis Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.4 Alnylam
  2.4.1 Business Overview
  2.4.2 Familial Amyloid Polyneuropathy Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 Alnylam Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.5 Corino Therapeutics
  2.5.1 Business Overview
  2.5.2 Familial Amyloid Polyneuropathy Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Corino Therapeutics Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.6 Proclara Bioscience
  2.6.1 Business Overview
  2.6.2 Familial Amyloid Polyneuropathy Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Proclara Bioscience Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
2.7 Arcturus Therapeutics
  2.7.1 Business Overview
  2.7.2 Familial Amyloid Polyneuropathy Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Arcturus Therapeutics Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL FAMILIAL AMYLOID POLYNEUROPATHY MARKET COMPETITION, BY PLAYERS

3.1 Global Familial Amyloid Polyneuropathy Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Familial Amyloid Polyneuropathy Players Market Share
  3.2.2 Top 10 Familial Amyloid Polyneuropathy Players Market Share
3.3 Market Competition Trend

4 GLOBAL FAMILIAL AMYLOID POLYNEUROPATHY MARKET SIZE BY REGIONS

4.1 Global Familial Amyloid Polyneuropathy Revenue and Market Share by Regions
4.2 North America Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
4.3 Europe Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
4.5 South America Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA FAMILIAL AMYLOID POLYNEUROPATHY REVENUE BY COUNTRIES

5.1 North America Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
5.2 USA Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
5.3 Canada Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
5.4 Mexico Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

6 EUROPE FAMILIAL AMYLOID POLYNEUROPATHY REVENUE BY COUNTRIES

6.1 Europe Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
6.2 Germany Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
6.3 UK Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
6.4 France Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
6.5 Russia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
6.6 Italy Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC FAMILIAL AMYLOID POLYNEUROPATHY REVENUE BY COUNTRIES

7.1 Asia-Pacific Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
7.2 China Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
7.3 Japan Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
7.4 Korea Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
7.5 India Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA FAMILIAL AMYLOID POLYNEUROPATHY REVENUE BY COUNTRIES

8.1 South America Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
8.2 Brazil Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
8.3 Argentina Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
8.4 Colombia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE FAMILIAL AMYLOID POLYNEUROPATHY BY COUNTRIES

9.1 Middle East and Africa Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
9.2 Saudi Arabia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
9.3 UAE Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
9.4 Egypt Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
9.5 Nigeria Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
9.6 South Africa Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)

10 GLOBAL FAMILIAL AMYLOID POLYNEUROPATHY MARKET SEGMENT BY TYPE

10.1 Global Familial Amyloid Polyneuropathy Revenue and Market Share by Type (2013-2018)
10.2 Global Familial Amyloid Polyneuropathy Market Forecast by Type (2018-2023)
10.3 FAP-I Revenue Growth Rate (2013-2023)
10.4 FAP-II Revenue Growth Rate (2013-2023)
10.5 FAP-III Revenue Growth Rate (2013-2023)
10.6 FAP-IV Revenue Growth Rate (2013-2023)

11 GLOBAL FAMILIAL AMYLOID POLYNEUROPATHY MARKET SEGMENT BY APPLICATION

11.1 Global Familial Amyloid Polyneuropathy Revenue Market Share by Application (2013-2018)
11.2 Familial Amyloid Polyneuropathy Market Forecast by Application (2018-2023)
11.3 Hospitals and Clinics Revenue Growth (2013-2018)
11.4 Others Revenue Growth (2013-2018)

12 GLOBAL FAMILIAL AMYLOID POLYNEUROPATHY MARKET SIZE FORECAST (2018-2023)

12.1 Global Familial Amyloid Polyneuropathy Market Size Forecast (2018-2023)
12.2 Global Familial Amyloid Polyneuropathy Market Forecast by Regions (2018-2023)
12.3 North America Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
12.4 Europe Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
12.6 South America Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Familial Amyloid Polyneuropathy Picture
Table Product Specifications of Familial Amyloid Polyneuropathy
Table Global Familial Amyloid Polyneuropathy and Revenue (Million USD) Market Split by Product Type
Figure Global Familial Amyloid Polyneuropathy Revenue Market Share by Types in 2017
Figure FAP-I Picture
Figure FAP-II Picture
Figure FAP-III Picture
Figure FAP-IV Picture
Table Global Familial Amyloid Polyneuropathy Revenue (Million USD) by Application (2013-2023)
Figure Familial Amyloid Polyneuropathy Revenue Market Share by Applications in 2017
Figure Hospitals and Clinics Picture
Figure Others Picture
Table Global Market Familial Amyloid Polyneuropathy Revenue (Million USD) Comparison by Regions 2013-2023
Figure North America Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Europe Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Asia-Pacific Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure South America Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Middle East and Africa Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Figure Global Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (2013-2023)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Familial Amyloid Polyneuropathy Type and Applications
Table Pfizer Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table GSK Basic Information, Manufacturing Base and Competitors
Table GSK Familial Amyloid Polyneuropathy Type and Applications
Table GSK Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Ionis Basic Information, Manufacturing Base and Competitors
Table Ionis Familial Amyloid Polyneuropathy Type and Applications
Table Ionis Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Alnylam Basic Information, Manufacturing Base and Competitors
Table Alnylam Familial Amyloid Polyneuropathy Type and Applications
Table Alnylam Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Corino Therapeutics Basic Information, Manufacturing Base and Competitors
Table Corino Therapeutics Familial Amyloid Polyneuropathy Type and Applications
Table Corino Therapeutics Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Proclara Bioscience Basic Information, Manufacturing Base and Competitors
Table Proclara Bioscience Familial Amyloid Polyneuropathy Type and Applications
Table Proclara Bioscience Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Arcturus Therapeutics Basic Information, Manufacturing Base and Competitors
Table Arcturus Therapeutics Familial Amyloid Polyneuropathy Type and Applications
Table Arcturus Therapeutics Familial Amyloid Polyneuropathy Revenue, Gross Margin and Market Share (2016-2017)
Table Global Familial Amyloid Polyneuropathy Revenue (Million USD) by Players (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue Share by Players (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Players in 2016
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Players in 2017
Figure Global Top 5 Players Familial Amyloid Polyneuropathy Revenue Market Share in 2017
Figure Global Top 10 Players Familial Amyloid Polyneuropathy Revenue Market Share in 2017
Figure Global Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate (%) (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue (Million USD) by Regions (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue Market Share by Regions (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Market Share by Regions (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Market Share by Regions in 2017
Figure North America Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Europe Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure South America Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table North America Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
Table North America Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure North America Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure North America Familial Amyloid Polyneuropathy Revenue Market Share by Countries in 2017
Figure USA Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Canada Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Mexico Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table Europe Familial Amyloid Polyneuropathy Revenue (Million USD) by Countries (2013-2018)
Figure Europe Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure Europe Familial Amyloid Polyneuropathy Revenue Market Share by Countries in 2017
Figure Germany Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure UK Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure France Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Russia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Italy Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Familial Amyloid Polyneuropathy Revenue (Million USD) by Countries (2013-2018)
Figure Asia-Pacific Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure Asia-Pacific Familial Amyloid Polyneuropathy Revenue Market Share by Countries in 2017
Figure China Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Japan Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Korea Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure India Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Southeast Asia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table South America Familial Amyloid Polyneuropathy Revenue by Countries (2013-2018)
Table South America Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure South America Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure South America Familial Amyloid Polyneuropathy Revenue Market Share by Countries in 2017
Figure Brazil Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Argentina Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Colombia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Familial Amyloid Polyneuropathy Revenue (Million USD) by Countries (2013-2018)
Table Middle East and Africa Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Familial Amyloid Polyneuropathy Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Familial Amyloid Polyneuropathy Revenue Market Share by Countries in 2017
Figure Saudi Arabia Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure UAE Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Egypt Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure Nigeria Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Figure South Africa Familial Amyloid Polyneuropathy Revenue and Growth Rate (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue (Million USD) by Type (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue Share by Type (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Type (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Type in 2017
Table Global Familial Amyloid Polyneuropathy Revenue Forecast by Type (2018-2023)
Figure Global Familial Amyloid Polyneuropathy Market Share Forecast by Type (2018-2023)
Figure Global FAP-I Revenue Growth Rate (2013-2018)
Figure Global FAP-II Revenue Growth Rate (2013-2018)
Figure Global FAP-III Revenue Growth Rate (2013-2018)
Figure Global FAP-IV Revenue Growth Rate (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue by Application (2013-2018)
Table Global Familial Amyloid Polyneuropathy Revenue Share by Application (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Application (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue Share by Application in 2017
Table Global Familial Amyloid Polyneuropathy Revenue Forecast by Application (2018-2023)
Figure Global Familial Amyloid Polyneuropathy Market Share Forecast by Application (2018-2023)
Figure Global Hospitals and Clinics Revenue Growth Rate (2013-2018)
Figure Global Others Revenue Growth Rate (2013-2018)
Figure Global Familial Amyloid Polyneuropathy Revenue (Million USD) and Growth Rate Forecast (2018 -2023)
Table Global Familial Amyloid Polyneuropathy Revenue (Million USD) Forecast by Regions (2018-2023)
Figure Global Familial Amyloid Polyneuropathy Revenue Market Share Forecast by Regions (2018-2023)
Figure North America Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
Figure Europe Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
Figure Asia-Pacific Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
Figure South America Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)
Figure Middle East and Africa Familial Amyloid Polyneuropathy Revenue Market Forecast (2018-2023)